For Manuscript Submission, Check or Review Login please go to Submission Websites List.
For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.
Stroke in South Asia: A Systematic Review of Epidemiologic Literature from 1980 to 2010Kulshreshtha A.a, b · Anderson L.M.d · Goyal A.a, b · Keenan N.L.c
Departments of aEpidemiology and bMedicine, Emory University, and cDivision for Heart Disease and Stroke Prevention, CDC, Atlanta, Ga., and dWashington State Institute for Public Policy, Olympia, Wash., USA Corresponding Author
Ambar Kulshreshtha, MD, MPH
1518 Clifton Road NE, 2040L CNR
Emory University, Atlanta, GA 30322 (USA)
Tel. +1 214 504 5208
Background: Globally 15 million people have an acute stroke every year and one third of them die secondary to stroke events. Most research on stroke prevention and treatment is done in developed countries, yet more than 85% of strokes occur in developing countries. In particular, stroke remains an underrecognized cause of death and disability in South Asia. Methods: We conducted a systematic review to identify reliable and comparable epidemiological evidence on stroke in South Asia from 1980 to 2010. Publications were screened for eligibility to identify only population-based stroke studies. Results: Of the 71 studies retrieved, only 6 studies from South Asia gave us acceptable estimates of the burden of stroke. Population-based studies from South Asia have stroke prevalence in the range of 45–471 per 100,000. The age-adjusted incidence rate varied from approximately 145 per 100,000 to 262 per 100,000. Rural parts of South Asia have a lower stroke prevalence compared with urban areas. Conclusions: Our review highlights the paucity of research data in South Asia. This must be addressed in order to accurately determine the burden of stroke in South Asia, so that specific policy recommendations can be formulated to combat the stroke epidemic in this region.
© 2012 S. Karger AG, Basel
Stroke is a leading cause of death and disability globally . Each year, 5.7 million people die from stroke and it is the second most common cause of death worldwide (9.7% of all deaths), exceeded only by heart disease . Stroke often leaves its survivors with severe disabilities that cause emotional and economic hardships for both patients and their families. It also poses enormous costs to healthcare systems . Over 85% of strokes are reported from developing countries, however the proportion of funds directed towards prevention in these countries remains insufficient [4,5,6,7]. A recent systematic review of trends in global stroke incidence has reported a divergence between developed countries (42% reduction) and developing countries (100% increase) over the past 4 decades . These variations could be attributed to widespread urbanization and consequent changing risk factor profiles, and lack of adequate prevention and treatment of stroke in developing countries.
Epidemiological studies in developing countries provide some evidence that stroke mortality rates tend to be as high as coronary heart disease rates . However, reliable statistics from many of these regions are not available. South Asia has over one fifth of the world’s population and is one of the most densely populated regions of the world. Health systems in this region have historically faced challenges such as infectious diseases, malnutrition, and high infant mortality. With increasing life expectancy, urbanization, and evolving patterns of diet and exercise in the last few decades, these economies are now facing an additional threat from chronic conditions like heart disease, stroke, and cancer.
Several studies have suggested that South Asia has among the highest rates of cardiovascular diseases globally . Also, South Asians who have migrated to other regions are reported to have higher coronary heart disease rates compared with the native population [10,11]. However, there is minimal literature about stroke rates from South Asia and many of the current estimates have relied on hospital-based studies. Based on evidence from developed countries, almost one third of stroke patients are not admitted to hospital, thus leading to biases in such studies [12,13,14]. Access to healthcare facilities is a bigger problem in developing countries, where even fewer people with stroke obtain hospital-based care. Accurate knowledge of stroke risk factors, incidence, and prevalence from community-based studies is important to develop public health interventions that reduce the stroke burden in such regions. The purpose of our systematic review is to identify reliable and comparable epidemiological evidence of stroke in community settings in South Asia and to summarize estimates of incidence, prevalence, and case fatality.
Stroke represents a constellation of neurologic signs and symptoms that are caused by cerebral infarction, cerebral hemorrhage, or subarachnoid hemorrhage. In this systematic review, we used the World Health Organization case definition of stroke: ‘rapidly developing clinical signs of focal (or global) disturbance of cerebral function, with symptoms lasting 24 h or longer or leading to death, with no apparent cause other than of vascular origin’ . The stroke types included: ischemic stroke, hemorrhagic stroke, and subarachnoid hemorrhage, but not transient ischemic attack. Using broad search terms relevant to cerebrovascular disease, we searched Medline, EMBASE, Global Health Database, and WHO regional databases from 1980 through 2010 for population-based reports on stroke incidence, prevalence, case fatality, and mortality in South Asia. We also conducted searches combining stroke terms with the following country names: Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka. Reference lists of relevant published articles were screened for any papers missed in our literature searches. Finally, we requested published or unpublished data using online discussion groups (ProCor, World Stroke Foundation, and World Heart Federation) and direct communication with colleagues working in South Asia. All articles and published abstracts in English and any other languages relevant to stroke in South Asia were included. Additional searches were conducted in regional journals that are not indexed in Medline or EMBASE.
Publications were screened for eligibility in two stages to identify stroke data that were population-based (those that reported fatal and nonfatal strokes in the community). In the first round, we screened all titles and abstracts for potential eligibility. Specifically, titles and abstracts were included if they were population-based studies conducted in any South Asian country and they examined incidence, prevalence, case fatality or stroke-specific mortality for the period 1980 to 2010. Results of this literature search were stored in a Reference Manager 12 bibliographic database (Thomson Reuters, New York). In the second round, all potentially eligible titles were retrieved in full text and reviewed according to predefined criteria. We extracted data on year of survey, duration of study, country, location, characteristics of participants, sampling methods, response rate, sample size, definition of stroke, measurement tools, representativeness, and strengths and limitations of each study. An adaptation of the STROBE guidelines (strengthening the reporting of observational studies in epidemiology) was used to characterize potential risk of bias in these studies . Standard protocol and data collection forms were used and uncertainties were resolved by discussion with authors. Information from included studies was abstracted and coded in a Microsoft Access data form by a trained study reviewer using a standard protocol. The database was screened periodically for duplicate citations. Finally, two authors independently assessed a random 20% of the abstracted papers for consistency. A formal meta-analysis was not undertaken because of the high degree of heterogeneity in the study methods and participants of the included studies.
The flow chart in figure 1 summarizes the literature search and selection process. In the first stage of screening, we retrieved 71 potential studies. After excluding nonrelevant studies, 32 articles were reviewed fully for detailed abstraction. In the past 3 decades, only 6 studies from this region met eligibility criteria for providing information about the burden of stroke in the South Asia region [17,18,19,20,21,22]. All of these studies were from India (tables 1, 2). There were only 3 longitudinal studies that reported on incidence measures.
Studies with a rigorous case ascertainment provide the most robust information about stroke incidence. These studies, however, are rare in developing countries as they require considerable resources. From the few longitudinal studies in South Asia, the reported crude stroke incidence is in the range of 123–145 per 100,000 [20,21,22]. The age-adjusted incidence rate varied from 145 per 100,000 to 262 per 100,000 [20,21] (table 2). Prevalence has been more commonly reported from the community-based surveys and it is estimated to be in the range of 45–471 per 100,000 [18,21]. Age-adjusted prevalence, however, is reported to be much higher and varies from 47 per 100,000 to 545 per 100,000 [18,21]. As in other developing countries, house-to-house surveys were often done as they are simple, efficient, and can be implemented in different settings.
Data on mortality can be obtained, but the accuracy of death certificate information on cause of death is often questionable . Furthermore, they provide information only about fatal cases of stroke and not the proportion of stroke survivors who may be living with major disability. Very few studies in South Asia provided any information about stroke mortality. A population-based longitudinal study on stroke was undertaken in the city of Kolkata, India, to determine the subtypes, prevalence, incidence, and case fatality rates of stroke. Thirty-day case fatality rate was reported to be 41% (95% CI = 31–54) and it was slightly greater for women (43%; 95% CI = 30–61) than men (38%; 95% CI = 24–59). Most deaths (86%) occurred among those aged 50 years and older .
According to the World Bank, 70% of the South Asian population lives in rural areas and primarily relies on agriculture for their livelihood. Differences in rural-urban prevalence are of significant interest to better understand and control for stroke and its risk factors in these countries. Urban parts of South Asia have been shown to have higher prevalence of coronary artery disease and stroke . In our screening, we found 3 studies that were done exclusively in rural areas. Our review shows that community surveys in rural parts of South Asia have a lower stroke prevalence in the range of 45–143 per 100,000 compared with the reported prevalence of 147–471 per 100,000 in urban areas [17,18,19,21].
Risk factors and underlying causes of stroke differ significantly in young individuals compared to adults. Stroke events in the economically productive younger age group may lead to an additional burden for developing countries. We found no population-based study in South Asia that specifically looked at stroke and its risk factors in young adults. A community-based study in the Pashtun population in Karachi in Pakistan reported that 30% of all strokes occurred at the age of less than 45 years . Another case-control study was conducted in a tertiary care referral center in southern India which provided information of stroke in the young . The above screened studies were, however, excluded from our final review because of lack of a clear description of methods, although they provide some insights into stroke in the young. Increasing evidence suggests that sex differences exist in the etiology, management and outcome of stroke [27,28]. A survey done in Kolkata revealed the age-specific prevalence rate of stroke to be higher in women than in men in all age groups except in the 50- to 69-year age range . A study by Bhattacharya et al.  in 2005 reported the sex-specific incidence (after age adjustment) to be 274 in women and 253 in men per 100,000.
Population studies in South Asia have generally not specified the stroke classification or type of infarction due to limited diagnostic facilities in this region. In the Mumbai Stroke Registry, 80% had ischemic stroke, 15% had intracerebral hemorrhage, 3% had subarachnoid hemorrhage and 2% were unspecified . A longitudinal study conducted in Kolkata, India provided information on stroke subtypes with ischemic stroke reported as the most common subtype, and the ratio of infarction to hemorrhage was 1.9 . Studies from South Asia have reported a similar risk factor profile as in other countries, with hypertension being the most frequent risk factor present, followed by smoking and diabetes [19,20].
The lack of high-quality stroke epidemiology data in developing countries is widely acknowledged by researchers and the World Health Organization . In our systematic review of South Asia, few community-based epidemiological studies have been conducted to give a reliable estimate of the stroke burden. Only 6 studies in the last 3 decades provide reliable estimates of stroke epidemiology. All of these studies were from India, which may not yield a fair representation of the other countries in this region. Several studies that were screened had methodological weaknesses such as unclear sampling methodology, incomplete case ascertainment for valid estimation of stroke incidence, invalidated survey instruments, different definitions of stroke, no mention of a reference population used for standardization, and limited information about stroke subtypes to allow meaningful comparisons.
Age-adjusted stroke incidence rates in high-income countries have decreased from 163 per 100,000 in 1970–1979 to 94 per 100,000 in 2000–2008, while in low- to middle-income countries the stroke incidence rates more than doubled (52 per 100,000 to 117 per 100,000, respectively) . Age-adjusted incident rates reported in South Asia are higher (145–262 per 100,000) compared with other developing countries . Studies of migrant South Asian populations in developed countries have similarly reported a higher incidence of stroke . In neighboring countries such as China, the stroke incidence has been estimated to be 115–219 per 100,000 with intracerebral hemorrhage responsible for a vast majority of strokes . In South Asia, ischemic stroke is the predominant stroke subtype similar to other regions of the world [22,29]. Epidemiological studies of age-adjusted prevalence in other countries have reported a higher rate of stroke, i.e. 500–800 per 100,000 [32,33,34]. However, studies in South Asia report a lower age-adjusted prevalence of about 47–545 per 100,000 . These lower prevalence rates in this region could be caused by a higher case fatality rate compared with other regions . There are limited valid data on stroke-related mortality in South Asia, as ascertainment of cause of death is inadequate . In a Karachi-based study, in-hospital stroke mortality was reported to be 11% . Our review suggests that there are sex-specific differences, and women have higher rates of stroke incidence and prevalence in South Asia . Previous studies have shown that the prevalence of metabolic syndrome (in particular obesity) in Asian Indian women is 1.5–2.0 times higher as compared with men [37,38,39,40]. It is possible that many conventional risk factors like hypertension and diabetes are less well-managed in women than men. Further, studies on prevalence of smoking are lacking in South Asia women. More data are needed to better characterize and understand the prevalence and increased risk of stroke and its risk factors in the South Asian population.
Studies in South Asia suggest that with increasing urbanization level there is a general increase in stroke prevalence, and this is similar to trends observed in few other developing countries [41,42,43]. Comparing regional and temporal changes in stroke incidence is important for the understanding of stroke and its risk factors. For South Asia, there was little information to comment on temporal trends in stroke incidence, as studies were undertaken at different time periods in different areas. The WHO-MONICA study was designed to monitor trends in the incidence of myocardial infarction and stroke and prevalence of risk factors, but it excluded many developing countries . Recently, the INTERSTROKE study, a case-control study from 22 developed and developing countries, identified 10 risk factors that accounted for 90% of the population-attributable risk of stroke . Modification of these risk factors through healthy lifestyle changes could substantially reduce the incidence of stroke in many of these countries. However, continuous surveillance of stroke and its risk factors to ascertain temporal trends is expensive and deemed impractical in most developing countries. A proposed solution has been to conduct a population-based incidence study in the same population once every decade .
Between 1990 and 2020, stroke is expected to increase by 120% for women and 137% for men in developing countries as compared with an increase of 30–60% in developed countries . However, financial resources for stroke prevention and treatment programs remain inadequate to meet the growing stroke burden in developing countries in the coming decades. Large-scale and better designed epidemiologic studies, standardized registries, population-based stroke prevention programs, and improved surveillance systems are urgently needed to prevent, detect and treat stroke and its risk factors. Through our systematic review, we made a rigorous attempt to identify published reports on stroke in South Asia and critically assess the quality of these studies with strict criteria. Stroke studies that were population-based and methodologically comparable were included in the analyses. We excluded hospital-based studies as they are not reflective of the stroke burden in the community. Our systematic review is dependent on the quality of contributing studies and has a few limitations. First, although the world population and United States population was commonly used as standard, some of the older papers do not mention the reference population used for age adjustment and thus the adjusted rates may not be uniformly comparable. Second, there is no information in these studies about recurrent stroke events. It is possible that inclusion of recurrent events might have inflated our incident stroke rate, since people who have already had a stroke would be expected to have higher rates of recurrent events. Finally, although we made efforts to obtain unpublished data, it is difficult to identify all potential sources of unpublished data and thus a publication bias is still possible. However, inclusion of unpublished data will expose our review to data of lesser quality as these studies have not been vetted through the peer review process. Rigorous epidemiological studies can provide reliable estimates, assess time trends for valid comparisons, and yield data that would assist in improved planning of healthcare within these countries.
The burden of stroke is underappreciated in South Asia. Levels of prevention, detection and treatment are extremely low, and the burden of stroke is projected to grow tremendously in the foreseeable future. In our systematic review, only 6 studies from South Asia provided acceptable estimates of the burden of stroke. There is a need for high-quality epidemiological studies in South Asia to monitor stroke incidence and prevalence, and to allow meaningful comparisons globally. Public health education and prevention efforts can be enhanced with well-designed population-based studies in South Asia to mitigate the stroke epidemic.
The authors thank Dr. George Mensah and Dr. Valery Feign for their advice and suggestions on the manuscript.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. There were no financial disclosures from any author.
Ambar Kulshreshtha, MD, MPH
1518 Clifton Road NE, 2040L CNR
Emory University, Atlanta, GA 30322 (USA)
Tel. +1 214 504 5208
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.